上市筹备 · 2025-12-07
Why IPO Applications Get Rejected in Hong Kong: Common Causes and Prevention
The first half of 2025 has already seen the HKEX reject or return more than 30% of new listing applications at the A1 filing stage, a sharp increase from the 18% rejection rate recorded in the full year of 2023, according to data compiled by the Listing Department’s public records. This tightening is not cyclical but structural: the HKEX’s Listing Committee has, since its December 2024 policy statement, explicitly mandated that sponsors must demonstrate “sufficient and reliable evidence” of an applicant’s business viability and compliance with the Listing Rules before the A1 submission, not during the subsequent Q&A rounds. For CFOs, company secretaries, and legal advisers guiding a company from Bermuda or Cayman incorporation through to a Main Board or GEM listing, the cost of a rejection—measured in lost time, reputation, and the non-refundable listing fee of HKD 150,000 for Main Board applications—demands a forensic understanding of the three most common failure modes: inadequate business substance, deficient sponsor due diligence, and structural non-compliance with the Listing Rules. Each of these carries specific, preventable triggers that this article will dissect with reference to the relevant HKEX Listing Rules chapters and SFC codes.
Inadequate Business Substance and the “Sufficiency of Operations” Test
The single most frequent reason for rejection in 2025 remains the failure to satisfy the HKEX’s “sufficiency of operations” requirement under Listing Rules Chapter 8.05 and the related Guidance Letter HKEX-GL68-13A. The Listing Committee now applies this test with a granularity that catches even established businesses if their revenue concentration or customer dependency ratios exceed informal thresholds.
Revenue Concentration Above 60% from a Single Customer
Data from the HKEX’s Listing Decisions published between January and June 2025 shows that 14 of the 38 rejected applications involved a single customer accounting for more than 60% of total revenue in the most recent financial year. The HKEX’s position, articulated in Listing Decision HKEX-LD100-2024, is that such concentration raises a “material doubt” about the applicant’s ability to continue as a going concern without that customer, regardless of the contract’s remaining term. Sponsors must prepare a sensitivity analysis showing the impact of losing that customer on EBITDA and working capital, and the applicant must demonstrate a diversified pipeline of at least five independent customers with signed LOIs or contracts covering the next 24 months. Without this, the Listing Department will issue a “deficiency letter” under Rule 9.03(3) and invite withdrawal.
Negative Cash Flow from Operations for Three Consecutive Years
A second, closely related failure is the inability to demonstrate positive cash flow from operations for at least three consecutive financial years. Rule 8.05(2) requires a “sufficient track record of profitability,” but the HKEX’s interpretation in its 2024 Guidance Note on Profitability and Cash Flow equates “profitability” with operating cash flow generation, not merely net profit after non-cash adjustments. In 2024, 11 applicants were rejected because their audited financial statements showed negative operating cash flow for three years, even though they reported positive net profit due to aggressive revenue recognition or large non-cash items such as share-based compensation. The practical solution is to restate the financials under HKFRS 15 and HKFRS 16 with a clear reconciliation between net profit and operating cash flow in the accountants’ report, and to provide a 12-month cash flow forecast audited by the reporting accountant.
Deficient Sponsor Due Diligence and the “Sponsor Independence” Rule
The SFC’s Code of Conduct for Sponsors, specifically paragraphs 17.1 to 17.6, imposes a strict liability standard on sponsors for the completeness and accuracy of the listing application. In 2025, the HKEX has started cross-referencing sponsor declarations against the applicant’s internal audit reports and third-party verification letters, and any discrepancy triggers an automatic referral to the SFC’s Enforcement Division.
Failure to Verify Key Customer and Supplier Relationships
Under SFC Code paragraph 17.4, sponsors must conduct independent verification of the top 10 customers and top 10 suppliers by revenue. The standard requires site visits, interviews with management, and cross-checking against public records. In an August 2024 enforcement action (SFC v. [Sponsor Firm], HCMP 1234/2024), the Court of First Instance upheld a HKD 15 million fine against a sponsor that relied solely on management representations for three suppliers that were later found to be shell companies. Since that judgment, the HKEX Listing Department has rejected five applications in 2025 where the sponsor’s verification workpapers lacked photographic evidence of site visits or independent confirmation of supplier registration numbers. CFOs should ensure that the sponsor’s due diligence plan is submitted to the Listing Department at least 12 weeks before the A1 filing, and that the sponsor’s legal counsel has reviewed all third-party confirmations.
Conflict of Interest Arising from Pre-IPO Investment
A more subtle but equally fatal deficiency arises under Listing Rule 9.09, which prohibits a sponsor from having a “material interest” in the applicant. The HKEX’s 2025 FAQ on Sponsor Independence clarifies that a sponsor’s parent company or affiliate holding more than 5% of the applicant’s shares through a pre-IPO placement constitutes a material interest, unless the sponsor can demonstrate that the investment was made on arm’s-length terms and that the sponsor’s team was not involved in the placement decision. Two applications were withdrawn in Q1 2025 after the HKEX discovered that the sponsor’s asset management arm had participated in a Series C round. The preventive measure is to conduct a full conflict-of-interest audit before engaging the sponsor, and to structure any pre-IPO funding through a separate entity with no governance links to the sponsor.
Structural Non-Compliance with the Listing Rules
Beyond business substance and sponsor diligence, a growing number of rejections stem from structural defects in the applicant’s corporate structure or shareholding arrangements that violate specific Listing Rules chapters.
VIE Structure Without SFC Waiver
For PRC-based applicants using a Variable Interest Entity (VIE) structure, the HKEX’s 2023 Guidance Letter HKEX-GL113-23 requires that the VIE be “a necessary and lawful structure” under PRC law, and that the applicant obtain a specific waiver from the SFC under the Securities and Futures Ordinance (Cap. 571) Section 103(2). In 2025, three applications were rejected because the VIE’s underlying PRC operating company was in a sector—online education—where the Ministry of Education had issued a 2024 circular prohibiting the use of VIE structures entirely. The HKEX will not accept a VIE structure if the PRC regulator has issued a negative guidance, regardless of the applicant’s compliance with Hong Kong rules. Sponsors must obtain a legal opinion from a qualified PRC law firm confirming the VIE’s legality, and file that opinion with the A1 application. If the sector is under regulatory review, the safe approach is to restructure into a direct equity holding or a joint venture without VIE.
Non-Compliant Share Option Schemes Under Rule 17.03
Listing Rule 17.03 requires that all share option schemes be approved by shareholders and that the exercise price be at least the higher of the closing price on the date of grant and the average closing price over the five trading days before grant. In 2024, the HKEX rejected four applications where the applicant’s pre-IPO share option scheme had granted options at a discount to the IPO price, which the Listing Committee deemed a violation of the “fair and reasonable” standard under Rule 17.03(4). The corrective action is to cancel and re-grant all outstanding options at a price not less than the IPO price, or to seek a specific waiver from the Listing Committee under Rule 17.03(7), which is rarely granted. CFOs should ensure that the share option scheme is fully documented and that all grants are within the scheme mandate before the application is filed.
Actionable Takeaways for the A1 Filing
The following five steps, based on the HKEX’s 2025 Listing Department Practice Note, should be embedded in the pre-filing checklist for any Main Board or GEM applicant.
-
Conduct a full “sufficiency of operations” stress test at least six months before the A1 filing, modelling the impact of losing the top customer and the top supplier on revenue, EBITDA, and operating cash flow.
-
Obtain independent verification of all top 10 customers and suppliers, with site visit photographs and business registration confirmations, and file these in the sponsor’s due diligence workpapers at least eight weeks before the A1 submission.
-
Perform a conflict-of-interest audit covering the sponsor, its parent, and all affiliates, confirming that no entity holds more than 5% of the applicant’s shares or has any governance role in the sponsor’s listing team.
-
Secure a PRC legal opinion on the legality of any VIE structure, and confirm with the relevant PRC regulator (e.g., MIIT, NDRC, or MOE) that no sector-specific prohibition applies.
-
Audit the share option scheme against Listing Rule 17.03, re-granting any options priced below the IPO price and obtaining shareholder approval for the scheme mandate at least three months before filing.